Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Tekmira, Quark, and More

Premium

Title: Lipid-containing Formulations

Patent Number: 8,642,076

Filed: Aug. 16, 2011

Lead Inventor: Muthiah Manoharan, Tekmira Pharmaceuticals (Alnylam Pharmaceuticals)


Title: Therapeutic Uses of Inhibitors of RTP801

Patent Number: 8,642,571

Filed: Aug. 31, 2012

Lead Inventor: Elena Feinstein, Quark Pharmaceuticals


Title: microRNA Inhibitors Comprising Locked Nucleotides

Patent Number: 8,642,751

Filed: Dec. 15, 2011

Lead Inventor: Christina Dalby, Miragen Therapeutics


Title: Detection of RNA in Tissue Samples

Patent Number: 8,644,580

Filed: Aug. 7, 2009

Inventor: David Lynch, Cambridge Research & Instrumentation

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.